Page last updated: 2024-09-04

combivir and didanosine

combivir has been researched along with didanosine in 1 studies

Compound Research Comparison

Studies (combivir)	Trials (combivir)	Recent Studies (post-2010) (combivir)	Studies (didanosine)	Trials (didanosine)	Recent Studies (post-2010) (didanosine)
122	32	59	2,054	459	166

Protein Interaction Comparison

Protein	Taxonomy	combivir (IC50)	didanosine (IC50)
Reverse transcriptase/RNaseH	Human immunodeficiency virus 1		6.26

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cooper, V; Fisher, M; Gellaitry, G; Horne, R; Lange, AC; Vrijens, B; White, D	1

Trials

1 trial(s) available for combivir and didanosine

Article	Year
The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study. Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 53, Issue:3 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Culture; Cyclopropanes; Didanosine; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Surveys and Questionnaires; Zidovudine	2010

Article

Year

The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study.

Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 53, Issue:3

Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Culture; Cyclopropanes; Didanosine; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Surveys and Questionnaires; Zidovudine

2010